News

Eli Lilly Q2 Preview: Can Mounjaro and Zepbound Keep Delivering?

Eli Lilly & Co. reports Q2 2025 results before the U.S. market opens on August 7. Analysts expect revenue of approximately ...

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...

Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in ...
Pharmaceutical Technology on MSN1d

UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...
Investor's Business Daily on MSN1d

Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure Mounts

Eli Lilly said Thursday it will hike the UK list price of its diabetes and weight-loss drug Mounjaro by up to 170%.

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy ...